Remedee Labs

Remedee Labs is a France-based Health Care startup that recently secured a €12.20M Series A investment on 06 December 2022 from a group of prominent investors including Bpifrance, C4 Ventures, Partech Partners, Supernova Invest, BNP Paribas, Caisse d'Epargne Rhone Alpes, Banque Hottinguer, Generali France, Banques Populaires, and Artois Investment. The company, established in 2016, is committed to revolutionizing chronic pain management through a patient-centric digital service platform. Remedee Labs has developed the world's first endorphin stimulator for personal use after a decade of exhaustive pre-clinical and clinical research. With over 1.5 billion people worldwide enduring chronic pain and a significant portion dissatisfied with their treatment, Remedee Labs aims to offer these patients a new lease on life. Leveraging its technology and close collaboration with medical practitioners, the company aspires to bring about a paradigm shift in chronic pain management, offering a ray of hope for millions around the globe.